CorporateAstraZeneca, Bristol Myers in Early Talks for Potential $400 Bn Pharma MergerBY Outlook Business Desk
CorporateDr Reddy's Secures US FDA Approval for Rituximab Biosimilar, Expands Biologics PortfolioBY Outlook Business Desk
CorporateNovo Nordisk Seeks US Court Order to Halt Eli Lilly's Weight-Loss Drug AdsBY Outlook Business Desk
MarketsNifty Pharma Drops 2%; Sensex, Nifty Open Weak Amid Rising Crude PricesBY Outlook Business Desk
MarketsBroad-Based Rally Lifts Markets; Sensex Rises 291 Points, Nifty Tops 24,102BY Outlook Business Desk
Union Budget 2026Pharma Industry Seeks R&D Sops, Simplification of Regulatory Framework in BudgetBY PTI
MarketsSudeep Pharma IPO Sees Strong Day 2 Bidding; Here's What Brokerages SayBY Outlook Business Desk
CorporateUS Pharma Firm Eli Lilly Partners with Cipla to Sell Weight-loss Drug in India under Brand Name ‘Yurpeak’BY Outlook Business Desk
CorporateWelcure Board Considers Telexcell Offer for Up to 25% Stake; Rejects Demand for ControlBY PTI
Economy & PolicyAmid Air of Uncertainty with Tariffs, Indian Pharma Firms May Look at More Third-party ManufacturingBY Outlook Business Desk
NewsTrump Targets Pharma Ads — New Rules for TV, Social Media & Telehealth: Here’s What Led to ItBY Outlook Business Desk
CorporateAmansa Investments Pumps ₹250 Cr in Rubicon Research in Pre-IPO Funding Round; Issue by Year-EndBY PTI
